[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
Purchase Options:
[Skip to Content Landing]

July 2020 - July 1883

Decade

Year

Issue

May 26, 2020, Vol 323, No. 20, Pages 1989-2104

In This Issue of JAMA

Audio Highlights

Abstract Full Text
free access online only has audio
JAMA. 2020;323(20):e200022. doi:10.1001/jama.2020.0022
Original Investigation

Effect of Doxycycline on Aneurysm Growth Among Patients With Small Infrarenal Abdominal Aortic Aneurysms: A Randomized Clinical Trial

Abstract Full Text
JAMA. 2020;323(20):2029-2038. doi:10.1001/jama.2020.5230

This randomized trial compares the effect of doxycycline with placebo on reducing CT-measured abdominal aortic aneurysms over 2 years among patients with small infrarenal abdominal aortic aneurysms.

Effect of Antihypertensive Medication Reduction vs Usual Care on Short-term Blood Pressure Control in Patients With Hypertension Aged 80 Years and Older: The OPTIMISE Randomized Clinical Trial

Abstract Full Text
has active quiz
JAMA. 2020;323(20):2039-2051. doi:10.1001/jama.2020.4871

This randomized clinical trial compares the effects of antihypertensive medication withdrawal vs usual care on systolic blood pressure (SBP) among adults ≥80 years with SBP <150 mm Hg receiving ≥2 blood pressure–lowering drugs.

Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area

Abstract Full Text
free access has active quiz has multimedia has audio
JAMA. 2020;323(20):2052-2059. doi:10.1001/jama.2020.6775

This case series describes clinical characteristics, health services use, and outcomes of patients with confirmed coronavirus disease 2019 (COVID-19) cared for at 12 hospitals of a single health system in the New York City (NYC) area.

Research Letter

Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens

Abstract Full Text
free access has active quiz
JAMA. 2020;323(20):2085-2086. doi:10.1001/jama.2020.6266

This study describes the prevalence of SARS-CoV-2 co-infection with noncoronavirus respiratory pathogens in a sample of symptomatic patients undergoing PCR testing in March 2020.

Symptom Screening at Illness Onset of Health Care Personnel With SARS-CoV-2 Infection in King County, Washington

Abstract Full Text
free access has active quiz
JAMA. 2020;323(20):2087-2089. doi:10.1001/jama.2020.6637

This study assessed the spectrum of initial symptoms at the onset of polymerase chain reaction–confirmed coronavirus disease 2019 (COVID-19) among health care personnel in King County, Washington.

Alterations in Smell or Taste in Mildly Symptomatic Outpatients With SARS-CoV-2 Infection

Abstract Full Text
free access has active quiz
JAMA. 2020;323(20):2089-2090. doi:10.1001/jama.2020.6771

This study reports on the prevalence, intensity, and timing of an altered sense of smell or taste in patients with SARS-CoV-2 infections.

Exposure to a Surrogate Measure of Contamination From Simulated Patients by Emergency Department Personnel Wearing Personal Protective Equipment

Abstract Full Text
free access has active quiz
JAMA. 2020;323(20):2091-2093. doi:10.1001/jama.2020.6633

This study uses an atomizer and fluorescent markers to simulate contamination of uncovered skin and hair of health care workers wearing personal protective equipment after intubating patient manikins under emergency conditions.

Prevalence, Types, and Sources of Bullying Reported by US General Surgery Residents in 2019

Abstract Full Text
JAMA. 2020;323(20):2093-2095. doi:10.1001/jama.2020.2901

This survey study describes surgical trainees’ self-reported experiences of bullying and symptoms of burnout and suicidality assessed at the time of their board certification examination.

US Preventive Services Task Force

Recommendation Statement

Primary Care–Based Interventions to Prevent Illicit Drug Use in Children, Adolescents, and Young Adults: US Preventive Services Task Force Recommendation Statement

Abstract Full Text
free access has active quiz has audio
JAMA. 2020;323(20):2060-2066. doi:10.1001/jama.2020.6774

This 2020 Recommendation Statement from the US Preventive Services Task Force concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care–based behavioral counseling interventions to prevent illicit drug use, including nonmedical use of prescription drugs, in children, adolescents, and young adults (I statement).

Evidence Report

Interventions to Prevent Illicit and Nonmedical Drug Use in Children, Adolescents, and Young Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force

Abstract Full Text
free access has audio
JAMA. 2020;323(20):2067-2079. doi:10.1001/jama.2020.1432

This systematic review to support the 2020 US Preventive Services Task Force Recommendation Statement on interventions to prevent illicit and nonmedical drug use summarizes published evidence on the benefits and harms of primary care–based interventions to prevent illicit and nonmedical drug use in children, adolescents, and young adults.

Viewpoint

COVID-19: Beyond Tomorrow

The Potential Effects of Coronavirus on National Health Expenditures

Abstract Full Text
has active quiz has multimedia has audio
JAMA. 2020;323(20):2001-2002. doi:10.1001/jama.2020.6644

This Viewpoint discusses the likely effects of the COVID-19 pandemic on US health care spending and on estimates of its share of gross domestic product (GDP).

COVID-19: Beyond Tomorrow

The Business of Medicine in the Era of COVID-19

Abstract Full Text
has active quiz
JAMA. 2020;323(20):2003-2004. doi:10.1001/jama.2020.7242

This Viewpoint discusses the shifting landscape of health care financing, regulation, and delivery as a result of the coronavirus pandemic, and discusses regulatory and other changes that need to be in place if telehealth and physician practice and hospital mergers become the “new normal” once the pandemic is controlled.

Oncology Practice During the COVID-19 Pandemic

Abstract Full Text
free access has active quiz
JAMA. 2020;323(20):2005-2006. doi:10.1001/jama.2020.6236

This Viewpoint proposes a framework for modifying cancer care in the midst of the COVID-19 pandemic that balances considerations about the time-sensitivity of patient need for visits and treatment, risk of infectious exposure, and hospital and staff capacity and stress.

Postacute Care Preparedness for COVID-19: Thinking Ahead

Abstract Full Text
free access has active quiz has audio
JAMA. 2020;323(20):2007-2008. doi:10.1001/jama.2020.4686

This Viewpoint discusses the second surge of COVID-19 patients on postacute care facilities and offers suggestions on how the medical community and policy makers should prepare by ensuring adequate infrastructure, staff training, and protective equipment.

Securing the Safety Net and Protecting Public Health During a Pandemic: Medicaid’s Response to COVID-19

Abstract Full Text
free access
JAMA. 2020;323(20):2009-2010. doi:10.1001/jama.2020.4272

This Viewpoint reviews options legally available to state Medicaid programs to respond to the COVID-19 pandemic, including increasing coverage of the uninsured, expanding telehealth capabilities, removing financial barriers to testing and treatment, and easing limits on drug prescriptions.

Social Media and Emergency Preparedness in Response to Novel Coronavirus

Abstract Full Text
free access has active quiz
JAMA. 2020;323(20):2011-2012. doi:10.1001/jama.2020.4469

This Viewpoint discusses the ways social media can be used as a critical tool in managing the COVID-19 outbreak, such as by directing users to trusted sources and counteracting misinformation, and how it can transform aspects of preparedness and response for the future.

Medical Education Takes a Step in the Right Direction: Where Does That Leave Students?

Abstract Full Text
JAMA. 2020;323(20):2013-2014. doi:10.1001/jama.2020.2950

This Viewpoint discusses possible unforeseen consequences of the announced 2022 change to USMLE Step 1 licensure examination results reporting from a 3-digit score to a pass/fail designation, including increased emphasis by programs on the scored Step 2 Clinical Knowledge examination and increased reliance on institutional reputations as criteria to recruit trainees.

Change in Reporting of USMLE Step 1 Scores and Potential Implications for International Medical Graduates

Abstract Full Text
JAMA. 2020;323(20):2015-2016. doi:10.1001/jama.2020.2956

This Viewpoint reviews the roles international medical graduates (IMGs) play in US health care systems and discusses the potential challenges that the announced 2022 change in USMLE Step 1 examination scoring from a 3-digit score to a pass/fail designation will pose for this workforce segment.

The USMLE Step 1 Decision: An Opportunity for Medical Education and Training

Abstract Full Text
has audio
JAMA. 2020;323(20):2017-2018. doi:10.1001/jama.2020.3198

This Viewpoint discusses the rationale for the announced 2022 change in USMLE Step 1 examination scoring from a 3-digit score to a pass/fail designation, addressing concerns that the change might lead to a shift in the importance of Step 2 Clinical Knowledge scores and emphasizing it as one part of a process to improve students’ transition into graduate medical education (GME) training programs.

A Piece of My Mind

Lost Space

Abstract Full Text
JAMA. 2020;323(20):2019-2020. doi:10.1001/jama.2020.7237

In this narrative medicine essay, an internist considers the effects of the coronavirus disease 2019 pandemic on noninfected patients whose access to care may be blocked by fear, economic loss, or an overwhelmed health care system.

Editorial

Health Care Heroes of the COVID-19 Pandemic

Abstract Full Text
free access
JAMA. 2020;323(20):2021. doi:10.1001/jama.2020.6197

The Pass/Fail Decision for USMLE Step 1—Next Steps

Abstract Full Text
JAMA. 2020;323(20):2022-2023. doi:10.1001/jama.2020.3938

Deprescribing Antihypertensive Medications for Patients Aged 80 Years or Older: Is Doing Less Doing No Harm?

Abstract Full Text
JAMA. 2020;323(20):2024-2026. doi:10.1001/jama.2020.4841

COVID-19 and Risks Posed to Personnel During Endotracheal Intubation

Abstract Full Text
free access has active quiz
JAMA. 2020;323(20):2027-2028. doi:10.1001/jama.2020.6627
JAMA Guide to Statistics and Methods

Nonparametric Statistical Analysis

Abstract Full Text
JAMA. 2020;323(20):2080-2081. doi:10.1001/jama.2020.5874

This JAMA Guide to Statistics and Methods reviews common types of nonparametric statistics, which make no assumptions about underlying population distribution, and explains when they are appropriate to use.

JAMA Insights

Clinical Update

Diagnosis and Treatment of Opioid Use Disorder in 2020

Abstract Full Text
JAMA. 2020;323(20):2082-2083. doi:10.1001/jama.2020.4104

This JAMA Insights Clinical Update reviews current approaches to screening for and managing opioid use disorder, summarizing available screening instruments, diagnostic criteria, and appropriate use of medication-assisted treatment (MAT), including methadone, buprenorphine, and naltrexone.

Medical News & Perspectives

Finding Ways to Reduce Coronavirus Exposure During Dialysis

Abstract Full Text
free access has active quiz has audio
JAMA. 2020;323(20):1993-1995. doi:10.1001/jama.2020.6158

This Medical News Feature examines what hemodialysis centers are doing to protect their high-risk patients from COVID-19.

The JAMA Forum

Emerging Lessons From COVID-19 Response in New York City

Abstract Full Text
free access
JAMA. 2020;323(20):1996-1997. doi:10.1001/jama.2020.7310
News From the Centers for Disease Control and Prevention

Nonfatal, Fatal Overdoses Rising

Abstract Full Text
JAMA. 2020;323(20):2000. doi:10.1001/jama.2020.7795

Hybrid Influenza Strain in Idaho

Abstract Full Text
JAMA. 2020;323(20):2000. doi:10.1001/jama.2020.6735
Clinical Trials Update

No Benefit for Lopinavir–Ritonavir in Severe COVID-19

Abstract Full Text
free access
JAMA. 2020;323(20):1999. doi:10.1001/jama.2020.6793

Daily Aspirin Not Neuroprotective in ASPREE Trial

Abstract Full Text
JAMA. 2020;323(20):1999. doi:10.1001/jama.2020.7967

Integrated Care Cut Mortality in Patients With Atrial Fibrillation

Abstract Full Text
JAMA. 2020;323(20):1999. doi:10.1001/jama.2020.7968

Gabapentin Treats Alcohol Use Disorder With Withdrawal Symptoms

Abstract Full Text
JAMA. 2020;323(20):1999. doi:10.1001/jama.2020.7969

Psoriasis Drug Guselkumab Improved Psoriatic Arthritis Symptoms

Abstract Full Text
JAMA. 2020;323(20):1999. doi:10.1001/jama.2020.7970
Health Agencies Update

Fish-Rich Mediterranean Diet Associated With Higher Cognition

Abstract Full Text
JAMA. 2020;323(20):1998. doi:10.1001/jama.2020.7061

Improper Drug Disposal After Patients on Home Hospice Care Die

Abstract Full Text
JAMA. 2020;323(20):1998. doi:10.1001/jama.2020.8128

Traumatic Brain Injury Hospital Stays Are Longer, More Costly

Abstract Full Text
JAMA. 2020;323(20):1998. doi:10.1001/jama.2020.8130
The Arts and Medicine

Nervous Breakdown-and-Across

Abstract Full Text
JAMA. 2020;323(20):1992. doi:10.1001/jama.2020.6812

This Arts and Medicine feature presents a neurology-themed crossword puzzle with clinical clues and other brain teasers.

Poetry and Medicine

Blue Madonna

Abstract Full Text
JAMA. 2020;323(20):2099. doi:10.1001/jama.2020.1813
JAMA Revisited

PELLAGRA

Abstract Full Text
JAMA. 2020;323(20):2100. doi:10.1001/jama.2019.13455
JAMA Patient Page

Masks and Coronavirus Disease 2019 (COVID-19)

Abstract Full Text
free access has active quiz
JAMA. 2020;323(20):2103. doi:10.1001/jama.2020.6437

This JAMA Patient Page describes who should wear face masks during the COVID-19 pandemic and provides suggestions for making masks at home and wearing them properly.

Interventions to Prevent Illicit Drug Use in Children, Adolescents, and Young Adults

Abstract Full Text
free access has audio
JAMA. 2020;323(20):2104. doi:10.1001/jama.2020.7122

This JAMA Patient Page summarizes the 2020 US Preventive Services Task Force recommendation concluding that evidence is insufficient to assess the balance of benefits and harms of primary care–based behavioral counseling interventions to prevent illicit drug use in children, adolescents, and young adults.

Comment & Response

Genital Powder Use and Ovarian Cancer

Abstract Full Text
JAMA. 2020;323(20):2095-2096. doi:10.1001/jama.2020.3855

Genital Powder Use and Ovarian Cancer

Abstract Full Text
JAMA. 2020;323(20):2096. doi:10.1001/jama.2020.3858

Genital Powder Use and Ovarian Cancer—Reply

Abstract Full Text
JAMA. 2020;323(20):2096-2097. doi:10.1001/jama.2020.3861

Ondansetron Use in Pregnancy and Congenital Malformations

Abstract Full Text
JAMA. 2020;323(20):2097. doi:10.1001/jama.2020.5064

Ondansetron Use in Pregnancy and Congenital Malformations—Reply

Abstract Full Text
JAMA. 2020;323(20):2097-2098. doi:10.1001/jama.2020.5067
Correction

Clarification of Mortality Rate and Data in Abstract, Results, and Table 2

Abstract Full Text
free access
JAMA. 2020;323(20):2098. doi:10.1001/jama.2020.7681
JAMA Masthead

JAMA

Abstract Full Text
free access
JAMA. 2020;323(20):1989-1990. doi:10.1001/jama.2019.13448
×